Geode Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-157,464
| Closed | -$3.63M | – | 4528 |
|
|
2020
Q4 | $3.63M | Sell |
157,464
-13,061
| -8% | -$301K | ﹤0.01% | 2766 |
|
|
2020
Q3 | $1.74M | Buy |
170,525
+6,705
| +4% | +$68.2K | ﹤0.01% | 2947 |
|
|
2020
Q2 | $2.44M | Buy |
163,820
+8,856
| +6% | +$132K | ﹤0.01% | 2733 |
|
|
2020
Q1 | $1.89M | Buy |
154,964
+56,199
| +57% | +$685K | ﹤0.01% | 2701 |
|
|
2019
Q4 | $1.56M | Buy |
98,765
+17,099
| +21% | +$271K | ﹤0.01% | 3110 |
|
|
2019
Q3 | $1M | Buy |
+81,666
| New | +$1M | ﹤0.01% | 3236 |
|